Wacker Chemie
Integrated B2B chemicals manufacturer selling into construction, automotive, electronics, semiconductor, solar, consumer care, pharma/biotech and food end-markets; capital-intensive plant-based production with a silicon-metal-to-silicones/polysilicon value chain.
Earnings, margins, COGS & capex
FY2025 was a cyclical trough: sales -4% to EUR 5.49B on weak chemical demand and depressed solar-grade polysilicon prices; reported EBITDA EUR 427M (-43%), EBITDA ex-specials EUR 529M (-29%); a net loss of EUR -805M (vs +261M) driven by ~EUR 600M of impairments/valuation adjustments led the board to scrap the dividend. Q1 2026 inflected: sales -5% to EUR 1.41B but EBITDA +45% to EUR 173M on the PACE cost program plus orders pulled forward (net income EUR 15M, EPS EUR 0.21), prompting a ~6% share pop and a raised 2026 sales guide (EBITDA guide unchanged).
Revenue trend
Margins
down 43% from ~13% in FY2024 (EUR 744M)
-29% YoY
swung from +EUR 261M profit in FY2024 on impairments
up sharply, +45% YoY on cost cuts
COGS structure
Cost base is energy- and raw-material-heavy: silicon metal, methanol, ethylene/VAM feedstocks, and very large electricity consumption (polysilicon and silicones production are power-intensive — a structural disadvantage given elevated German/European energy prices). Polysilicon economics are dominated by power cost and utilization; solar-grade prices have been crushed by Chinese oversupply. PACE targets EUR 200M gross cost savings in 2026 rising to more than EUR 300M annually by 2027-28, split production and administrative, and includes more than 1,500 job cuts.
Capex
FY2025 capex ~EUR 465M (~8.5% of sales, roughly on par with depreciation) after a multi-year heavy investment cycle (US Charleston TN polysilicon, specialty silicones, biologics/CDMO). Guided down to ~EUR 300M for 2026 as large projects complete and focus shifts to filling capacity.
Latest earnings
Beat — EBITDA EUR 173M vs ~EUR 119M prior year (+45%), well ahead of analyst consensus; net income EUR 15M (EPS EUR 0.21); shares rose ~6% and the FY2026 sales guide was raised to high-single-digit growth (EBITDA guide held at EUR 550-700M)
FY2026: sales growth high-single-digit % (raised from low-single-digit); EBITDA EUR 550-700M (unchanged); capex ~EUR 300M; net cash flow positive and materially higher; net financial debt down low-double-digit %
- Q1 2026 group EBITDA
- EUR 173M (+45% YoY), margin 12.3%
- Silicones Q1 2026 sales / EBITDA
- EUR 708M (-5%) / EUR 117M (+13%)
- Polymers Q1 2026 sales / EBITDA
- EUR 333M (-8%) / EUR 50M (+33%)
- Polysilicon Q1 2026 sales / EBITDA
- EUR 226M (-8%) / EUR 23M (-4%)
- Biosolutions Q1 2026 sales / EBITDA
- EUR 100M (+9%) / EUR 13M (+160%)
- FY2025 dividend
- EUR 0 — suspended after the net loss
Growth drivers
- PACE restructuring — EUR 200M (2026) -> more than EUR 300M (2027-28) gross savings driving EBITDA recovery independent of volume
- Semiconductor-grade polysilicon demand from AI/advanced-node chip buildout (a higher-margin, sticky niche vs solar-grade)
- Western (non-China) polysilicon premium — US IRA domestic-content rules and EU trade measures favor Wacker's US/German supply for onshoring solar & semis
- Silicones specialty mix — resilient EBITDA (Q1 2026 EBITDA +13% despite -5% sales) across cosmetics, medical, electronics, automotive, construction
- Biosolutions / biopharma CDMO (mRNA, biologics, cyclodextrins, food) as a structurally growing, less-cyclical leg — Q1 2026 EBITDA up sharply off a low base
Bull & bear
A cyclical materials leader trading near trough valuation with a self-help earnings lever (PACE) and structural tailwinds in Western semiconductor/solar supply — priced for despair while EBITDA has already inflected +45% in Q1 2026.
- Q1 2026 proved the inflection: EBITDA +45% YoY, back to net profit, FY sales outlook raised — the trough is likely in
- PACE delivers EUR 200M (2026) rising to more than EUR 300M (2027-28) of gross savings, lifting EBITDA toward the EUR 550-700M guide largely independent of volume recovery
- Semiconductor-grade polysilicon is a defensible oligopoly benefiting from AI chip demand and onshoring — higher-margin than solar-grade and hard to displace
- IRA/EU trade policy creates a non-China polysilicon premium that structurally favors Wacker's US (Charleston TN) and German capacity
- Silicones EBITDA proved resilient through the downturn; balance sheet (net debt ~EUR 886M) is manageable, and on mid-cycle EBITDA (EUR 900M-1B) the EV/EBITDA multiple compresses to ~5.5-6.5x — cheap
A structurally disadvantaged European producer whose largest swing factor (solar polysilicon) is in chronic Chinese-oversupply-driven loss territory, that just posted an EUR 805M loss, cut its dividend, and faces persistently high energy costs a cost program can only partly offset.
- Solar-grade polysilicon prices remain crushed by Chinese overcapacity (Tongwei, GCL, Daqo, Xinte) with no clear rationalization — Wacker's poly sales fell again (-8%) in Q1 2026
- FY2025 net loss of EUR 805M with ~EUR 600M of impairments signals the asset base may be worth less than carried; dividend suspension removes total-return support
- European energy and carbon costs are a permanent structural handicap in the most power-hungry processes vs China and US-Gulf peers
- Weak construction and automotive demand caps the silicones/polymers recovery; a relatively strong euro compounds export and translation pressure
- EBITDA (even at the EUR 700M guide top) is still well below 2024 and a fraction of the 2022 peak — the Q1 lift leaned on cost-out plus pulled-forward orders, not demand, and is fragile if the cycle stalls
What it is worth
EV/EBITDA vs cyclical peers + reverse read-through on mid-cycle normalization. EV ~= EUR 4.68B market cap + EUR 0.886B net debt ~= EUR 5.6B (~$6.3B). On FY2025 ex-special EBITDA (EUR 529M) that is ~10.5x; on the FY2026 guide midpoint (~EUR 625M) ~9x.
Solar-poly oversupply persists and forces further impairments; EBITDA stalls near EUR 500M and the dividend stays suspended, pressuring the stock toward EUR 65-80 on book-value and cash-flow support.
EBITDA settles in the guided EUR 550-700M range for 2026-27; cost-driven recovery holds the stock roughly range-bound around EUR 90-110 as demand stays soft.
Mid-cycle EBITDA of EUR 900M-1B (poly recovery + full PACE + semi/onshoring premium) implies ~5.5-6.5x EV/EBITDA on today's EV — re-rating toward EUR 130-160/share and dividend restoration.
The stock prices a trough: ~9x forward EV/EBITDA is above Wacker's mid-cycle norm (~4-6x) precisely because EBITDA is depressed. The swing is solar-polysilicon pricing and PACE delivery. Book-value support exists post-impairment; dividend restoration is the re-rating catalyst. Not financial advice; a non-US listing (Xetra) — no view is offered on China-based poly peers as ownership candidates.
SWOT
Strengths
- Vertically integrated, technology-leading position across four platforms; a top-tier global merchant in silicones and one of the few non-Chinese hyperpure polysilicon producers
- Semiconductor-grade polysilicon leadership — high purity, qualified supplier to wafer makers, a genuine oligopoly (Wacker, Hemlock, a few others)
- Resilient silicones franchise: Silicones EBITDA rose ~13% YoY in Q1 2026 despite lower sales
- Manageable balance sheet relative to the loss — net debt only ~EUR 886M against a ~EUR 4.7B market cap, giving room to fund PACE and ride out the trough
Weaknesses
- High exposure to European (German) energy prices in the most power-intensive processes — a persistent cost disadvantage vs Chinese and US-Gulf peers
- FY2025 net loss of EUR 805M and a scrapped dividend dent the total-return case and signal impairment risk in polysilicon
- Heavily cyclical, capex-intensive model with long asset lives — slow to reprice down in a demand air-pocket
- Solar-grade polysilicon is increasingly a commoditized, loss-adjacent business squeezed by Chinese oversupply
Opportunities
- Western supply-chain onshoring (US IRA domestic content, EU de-risking) creating a durable non-China polysilicon premium
- AI-driven semiconductor demand lifting hyperpure polysilicon and electronics-grade silicones
- PACE cost-out (more than EUR 300M by 2027-28) structurally resetting the margin floor
- Biosolutions/biopharma CDMO scale-up as a higher-growth, lower-cyclicality leg
Threats
- Chronic Chinese polysilicon overcapacity (Tongwei, GCL, Daqo, Xinte) keeping solar-grade prices below cash cost for the industry
- A relatively strong euro (~1.14 vs USD) compressing export competitiveness and translated earnings
- Prolonged weak construction/automotive demand hitting silicones and polymers volumes
- Energy-price and carbon-cost shocks in Europe; potential further impairments if the solar downturn persists
Moats, dependencies & bottlenecks
Moats
Hyperpure semiconductor-grade polysilicon technology & qualification Multi-year customer qualification and purity know-how create a narrow non-Chinese oligopoly (Wacker, Hemlock) for electronics-grade poly.
Moderate-Strong Silicon-metal-to-siloxane integration plus thousands of application-specific grades across regulated end-markets (medical, cosmetics, electronics) raise switching costs.
Multi-billion-EUR plants and long lead times deter new merchant entrants outside subsidized Chinese capacity.
Policy-dependent US IRA & EU de-risking confer a premium, but it is a policy moat that can shift with trade regimes.
Dependencies
Polysilicon and silicones are power-intensive; European power costs are a structural margin drag vs Chinese/US peers.
methanol, ethylene/VAM) Raw material supply Silicon-metal price/availability (Ferroglobe, Elkem) and petrochemical feedstocks drive COGS.
End-market / commodity price Solar-grade polysilicon P&L is set by the China-dominated global poly price, largely outside Wacker's control.
Customer concentration (niche) Electronics-grade poly depends on a handful of wafer makers (Shin-Etsu, SUMCO, GlobalWafers).
The non-China premium underpinning the poly recovery depends on policy continuity.
Advantages
- One of very few non-Chinese producers of hyperpure semiconductor-grade polysilicon
- Vertically integrated silicon-metal-to-silicones/polysilicon value chain
- US (Charleston, TN) plus German footprint positioning it for Western onshoring demand
- Diversified across four platforms and many end-markets, cushioning single-market shocks
- Self-help EBITDA lever (PACE) delivering savings largely independent of demand
Weaknesses
- Structural European energy-cost disadvantage in its most power-intensive processes
- Largest commodity exposure (solar polysilicon) is in a chronic oversupply downturn
- FY2025 net loss and dividend suspension; impairment risk if the poly cycle persists
- A relatively strong euro pressures export competitiveness and translated earnings
- Recovery is cost- and pull-forward-driven rather than demand-driven, leaving it fragile to a stalled cycle
Bottlenecks
- Chinese polysilicon overcapacity setting the global solar-grade price below the industry's cash cost
- European energy-cost structure limiting the achievable margin floor even after PACE cost-out
- Cyclical construction/automotive demand gating silicones and polymers volume recovery
- Capital intensity and long asset lives slowing the ability to reprice the cost base downward
Top signals & trends
Top signals
Bearish until Chinese capacity rationalizes · The single biggest swing factor for the poly segment P&L and impairment risk.
Bullish if on track · Q1 2026's +45% EBITDA already reflects early PACE traction plus pulled-forward orders.
Higher-margin demand that can offset solar-grade weakness.
Bearish at EUR strength (~1.14 in Jul 2026) · A strong euro pressures export margins and translated USD sales; company cited negative FX effects in Q1.
Management guides year-end net debt down and cash flow positive in 2026 — a dividend-restoration precondition (net debt ticked up to ~EUR 964M in Q1 on seasonal working capital).
Trends
Structural oversupply from Tongwei/GCL/Daqo/Xinte pressures the entire non-China poly industry.
Lifts hyperpure polysilicon and electronics-grade silicones; policy-supported Western capacity.
Creates a durable non-China polysilicon premium favoring Wacker's US/German assets.
Persistent structural cost handicap for energy-intensive European chemicals.
Caps silicones and VAE-polymer volume recovery.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Silicon-metal producer — a core feedstock for silicones and polysilicon.
Silicon-metal supplier (and silicones competitor) — dual relationship.
Methanol feedstock supplier for silicones production.
Petrochemical feedstocks (ethylene/VAM derivatives) for silicones and VAE polymers.
Large electricity offtake — the dominant variable cost for polysilicon.
Semiconductor wafer makers that buy hyperpure semiconductor-grade polysilicon — the higher-margin poly demand.
Buy solar-grade polysilicon; Western non-China buyers pay an IRA/EU premium (many large buyers are China-based — context only).
VAE dispersions/powders for adhesives, tile, EIFS; a large silicones/polymers end-market.
L'Oreal / Unilever (consumer-care & cosmetics) Silicone elastomers and fluids for personal care and cosmetics.
Silicone sealants, encapsulants and thermal materials for autos and electronics.
Biosolutions: cyclodextrins, cysteine, biologics/mRNA contract manufacturing.
Major global silicones producer (legacy Dow Corning) and broad materials overlap in polymers/dispersions.
Global leader in silicones AND semiconductor materials; competes in both silicones and (via silicon wafers) the semi supply chain — Japan.
Silicones + silicon-metal producer; both a competitor and up-chain supplier of silicon metal — Norway.
Large Chinese solar-grade polysilicon producer; emblematic of the oversupply pressuring Wacker's poly segment (China — context only, not a buy/own call).
Global silicones specialist; direct silicones competitor, privately held (KCC-led Korean consortium).
Key non-China semiconductor-grade polysilicon peer and the main Western competitor in hyperpure poly — US.
Competes in VAE/vinyl-acetate emulsions and specialty polymers overlapping Wacker's Polymers division.
Non-China polysilicon producer (Malaysia-based capacity) targeting the same Western premium market.